Active Ingredient History

  • Now
Cephaloglycin, first oral cephalosporin, was introduced in 1965, but is no longer in common use. It is an orally absorbed derivative of cephalosporin C. Cephaloglycin binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. PBPs are enzymes involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis.   NCATS

  • SMILES: CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=CC=C3)C2=O)C(O)=O
  • Mol. Mass: 405.425
  • ALogP: -0.01
  • ChEMBL Molecule:
More Chemistry
39435 | 7-(2-d-alpha-aminophenylacetamido)cephalosporanic acid | 7-(d-2-amino-2-phenylacetamido)-3-acetoxymethyl-delta(sup3)-cephem-4-carboxylic acid | 7-(d-alpha-aminophenyl-acetamido)cephalosporanic acid | cefaloglicina | cefaloglycin | cefaloglycine | cefaloglycinum | ceg | cephaloglycin | cephaloglycine | cephaoglycin acid | d-(-)-cephaloglycin | d-cephaloglycine | kafocin | kefglycin


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue